Lipid modifications mediate the subcellular localization and biological activity of many proteins, including endothelial nitric oxide synthase (eNOS). This enzyme resides on the cytoplasmic aspect of the Golgi apparatus and in caveolae and is dually acylated by both N-myristoylation and S-palmitoylation. Palmitoylation-deficient mutants of eNOS release less nitric oxide (NO). We identify enzymes that palmitoylate eNOS in vivo. Transfection of human embryonic kidney 293 cells with the complementary DNA (cDNA) for eNOS and 23 cDNA clones encoding the Asp-His-His-Cys motif (DHHC) palmitoyl transferase family members showed that five clones (2, 3, 7, 8, and 21) enhanced incorporation of [3H]-palmitate into eNOS. Human endothelial cells express all five of these enzymes, which colocalize with eNOS in the Golgi and plasma membrane and interact with eNOS. Importantly, inhibition of DHHC-21 palmitoyl transferase, but not DHHC-3, in human endothelial cells reduces eNOS palmitoylation, eNOS targeting, and stimulated NO production. Collectively, our data describe five new Golgi-targeted DHHC enzymes in human endothelial cells and suggest a regulatory role of DHHC-21 in governing eNOS localization and function.
Skip Nav Destination
Article navigation
31 July 2006
Article|
July 24 2006
Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase
Carlos Fernández-Hernando,
Carlos Fernández-Hernando
1Department of Pharmacology and Program in Vascular Cell Signaling and Therapeutics, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06536
Search for other works by this author on:
Masaki Fukata,
Masaki Fukata
2Laboratory of Genomics and Proteomics, National Institute for Longevity Sciences, Aichi 474-8522, Japan
3Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan
Search for other works by this author on:
Pascal N. Bernatchez,
Pascal N. Bernatchez
1Department of Pharmacology and Program in Vascular Cell Signaling and Therapeutics, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06536
Search for other works by this author on:
Yuko Fukata,
Yuko Fukata
2Laboratory of Genomics and Proteomics, National Institute for Longevity Sciences, Aichi 474-8522, Japan
Search for other works by this author on:
Michelle I. Lin,
Michelle I. Lin
1Department of Pharmacology and Program in Vascular Cell Signaling and Therapeutics, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06536
Search for other works by this author on:
David S. Bredt,
David S. Bredt
4Department of Integrative Biology, Eli Lilly and Company, Indianapolis, IN 46285
Search for other works by this author on:
William C. Sessa
William C. Sessa
1Department of Pharmacology and Program in Vascular Cell Signaling and Therapeutics, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06536
Search for other works by this author on:
Carlos Fernández-Hernando
1Department of Pharmacology and Program in Vascular Cell Signaling and Therapeutics, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06536
Masaki Fukata
2Laboratory of Genomics and Proteomics, National Institute for Longevity Sciences, Aichi 474-8522, Japan
3Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan
Pascal N. Bernatchez
1Department of Pharmacology and Program in Vascular Cell Signaling and Therapeutics, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06536
Yuko Fukata
2Laboratory of Genomics and Proteomics, National Institute for Longevity Sciences, Aichi 474-8522, Japan
Michelle I. Lin
1Department of Pharmacology and Program in Vascular Cell Signaling and Therapeutics, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06536
David S. Bredt
4Department of Integrative Biology, Eli Lilly and Company, Indianapolis, IN 46285
William C. Sessa
1Department of Pharmacology and Program in Vascular Cell Signaling and Therapeutics, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06536
Correspondence to William C. Sessa: [email protected]
Abbreviations used in this article: CRD, cysteine-rich domain; eNOS, endothelial NO synthase; HEK, human embryonic kidney; HUVEC, human umbilical vein endothelial cell; NO, nitric oxide; PAT, palmitoyl acyl transferase; WT, wild-type.
Received:
January 20 2006
Accepted:
June 22 2006
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2006
J Cell Biol (2006) 174 (3): 369–377.
Article history
Received:
January 20 2006
Accepted:
June 22 2006
Citation
Carlos Fernández-Hernando, Masaki Fukata, Pascal N. Bernatchez, Yuko Fukata, Michelle I. Lin, David S. Bredt, William C. Sessa; Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase . J Cell Biol 31 July 2006; 174 (3): 369–377. doi: https://doi.org/10.1083/jcb.200601051
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement